Pancreatic Cancer Research

ResearcherAalborg University HospitalActive in the last 2 years

Asbjørn Mohr Drewes

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7465-964X; OpenAlex author ID A5058714238, A5129689474. Sources: OpenAlex.

Their work

Papers
8 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
23
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper · 2024: 1 paper · 2025: 1 paper · 2026: 3 papers

Papers 8

  1. Pathophysiology, assessment, and treatment of pain in patients with pancreatic ductal adenocarcinoma. Last author DOI 10.1007/s00535-026-02423-3↗
  2. Pain profiles in pancreatic cancer and chronic pancreatitis: a multicenter cross-sectional analysis. Co-author DOI 10.3389/fpain.2026.1903789↗
  3. Widespread Hyperalgesia Predicts Mortality in Pancreatic Adenocarcinoma Co-author DOI 10.64898/2026.05.19.26353594↗
  4. Pancreatic adenocarcinoma patients with pain have abnormal central pain processing. Co-author DOI 10.1016/j.pan.2025.04.010↗
  5. Prediction of pancreatic cancer risk in patients with new-onset diabetes using a machine learning approach based on routine biochemical parameters. Co-author DOI 10.1016/j.cmpb.2023.107965↗
  6. Risk of pancreatic cancer in people with new-onset diabetes: A Danish nationwide population-based cohort study. Co-author DOI 10.1016/j.pan.2023.07.001↗
  7. Pain in pancreatic ductal adenocarcinoma: A multidisciplinary, International guideline for optimized management. Co-author DOI 10.1016/j.pan.2018.04.008↗
  8. Cell-free DNA promoter hypermethylation in plasma as a diagnostic marker for pancreatic adenocarcinoma. Co-author DOI 10.1186/s13148-016-0286-2↗

Closest collaborators

The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Søren Schou Olesen · 7 shared papers, 2018–2026 · strength 1.57
  2. Vikesh K. Singh · 5 shared papers, 2018–2026 · strength 1.10
  3. Marko Damm · 4 shared papers, 2025–2026 · strength 1.03
  4. Mahya Faghih · 4 shared papers, 2025–2026 · strength 1.03
  5. Marie-Theres Kassik · 3 shared papers, 2026 · strength 0.80
  6. Anna Evans Phillips · 3 shared papers, 2025–2026 · strength 0.75
  7. Dhiraj Yadav · 3 shared papers, 2025–2026 · strength 0.75
  8. Jonas Rosendahl · 3 shared papers, 2025–2026 · strength 0.75
  9. Daniel A. Laheru · 3 shared papers, 2025–2026 · strength 0.75
  10. Stine Dam Henriksen · 3 shared papers, 2016–2024 · strength 0.54
  11. Sophie Rauschenberg · 2 shared papers, 2026 · strength 0.52
  12. Lei Zheng · 2 shared papers, 2025–2026 · strength 0.49
  13. Simon Lebech Cichosz · 2 shared papers, 2023–2024 · strength 0.48
  14. Morten Hasselstrøm Jensen · 2 shared papers, 2023–2024 · strength 0.48
  15. Michael Hirth · 1 shared paper, 2026 · strength 0.28
  16. Patrick Michl · 1 shared paper, 2026 · strength 0.28
  17. John Albert Windsor · 1 shared paper, 2018 · strength 0.07
  18. Rupjyoti Talukdar · 1 shared paper, 2018 · strength 0.07
  19. Berta Laquente · 1 shared paper, 2018 · strength 0.07
  20. Pramod Kumar Garg · 1 shared paper, 2018 · strength 0.07
  21. Harry van Goor · 1 shared paper, 2018 · strength 0.07
  22. Guralp Onur Ceyhan · 1 shared paper, 2018 · strength 0.07
  23. Ole Thorlacius‐Ussing · 1 shared paper, 2016 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.